Dr. bycomet
@bycomet
薬事承認の根拠のひとつとなった第3相試験 Clarity AD(van Dyck, 2023)について https://paragraph.xyz/@smaller/lecanemab difference in cognitive function compared to placebo was smaller than the minimal clinically significant change
0 reply
0 recast
0 reaction